Brief: Astrazeneca Pharma India To Discontinue Manufacturing, Marketing Of Prolonged Release Isosorbide-5-Mononitrate Tablets BP
28/03/2025 09:49
March 28 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS: DISCONTINUING MANUFACTURING, MARKETING OF PROLONGED RELEASE ISOSORBIDE-5-MONONITRATE TABLETS BP Source text: [ID:] Further company coverage: ASTR.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan